UHS
UNIVERSAL HEALTH SERVICES, INC.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q4 2013 | 51Q | $76 | $169 | +121% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $220 | $169 | -23% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $220 | $169 | -23% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $220 | $169 | -23% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $220 | $169 | -23% |
| Two Sigma Investments re-entered | Q4 2024(8Q snapshot) | 6Q | $200 | $169 | -15% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Glenview Capital 3× in & out | Q1 2023 | Q1 2026 | → $235 | +61% |
| Point72 Asset Management 3× in & out | Q3 2025 | Q4 2025 | → $225 | +26% |
| Renaissance Technologies | Q3 2024 | Q3 2025 | → $178 | -17% |
| Maverick Capital 3× in & out | Q3 2023 | Q4 2023 | → $131 | +1% |
| Viking Global Investors 5× in & out | Q4 2016 | Q2 2018 | → $113 | -3% |
| JANA Partners | Q4 2016 | Q1 2018 | → $113 | -3% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at UNIVERSAL HEALTH SERVICES INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 29, 2026 — the most recent Form 4 on file — not from today.
- Form 40000352915-26-000058May 29, 2026
- Form 40000352915-26-000056May 21, 2026
- Form 40000352915-26-000053May 21, 2026
- Form 40000352915-26-000051May 21, 2026
- Form 40000352915-26-000047May 21, 2026
- Form 40000352915-26-000045May 21, 2026
- Form 40000352915-26-000043Mar 30, 2026
- Form 40000352915-26-000042Mar 30, 2026
- Form 40000352915-26-000041Mar 30, 2026
- Form 40000352915-26-000040Mar 30, 2026
- Form 40000352915-26-000039Mar 30, 2026
- Form 40000352915-26-000029Mar 23, 2026
- Form 40000352915-26-000027Mar 23, 2026
- Form 40000352915-26-000025Mar 23, 2026
- Form 40000352915-26-000023Mar 23, 2026
Fundamentals
XBRL · UNIVERSAL HEALTH SERVICES, INC.Annual figures sourced directly from UNIVERSAL HEALTH SERVICES, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for UNIVERSAL HEALTH SERVICES INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 22, 2026
- 8-KMaterial eventMay 21, 2026
- 10-QQuarterly reportMay 7, 2026
- 8-KMaterial eventApr 28, 2026
- 8-KMaterial eventApr 24, 2026
- DEF 14AProxy statementApr 9, 2026
- 8-KMaterial eventMar 30, 2026
- 8-KMaterial eventMar 9, 2026
- 8-KMaterial eventFeb 26, 2026
- 10-KAnnual reportFeb 25, 2026
- 8-KMaterial eventDec 31, 2025
- 10-QQuarterly reportNov 7, 2025
- 8-KMaterial eventOct 28, 2025
- 8-KMaterial eventSep 29, 2025
- 10-QQuarterly reportAug 8, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Two Sigma Investments | Q2 2026 | open | $169 | $169 | +0% |
| Point72 Asset Management | Q3 2025 | Q4 2025 | $178 | $225 | +26% |
| Point72 Asset Management | Q1 2025 | Q2 2025 | $181 | $195 | +8% |
| Two Sigma Investments | Q4 2024 | Q2 2025 | $200 | $195 | -2% |
| Citadel Advisors | Q3 2024 | open | $220 | $169 | -23% |
| D.E. Shaw | Q3 2024 | open | $220 | $169 | -23% |
| AQR Capital Management | Q3 2024 | open | $220 | $169 | -23% |
| Millennium Management | Q3 2024 | open | $220 | $169 | -23% |
| Point72 Asset Management | Q3 2024 | Q4 2024 | $220 | $200 | -9% |
| Renaissance Technologies | Q3 2024 | Q3 2025 | $214 | $178 | -17% |
| Maverick Capital | Q3 2023 | Q4 2023 | $130 | $131 | +1% |
| Glenview Capital | Q1 2023 | Q1 2026 | $146 | $235 | +61% |
| Bridgewater Associates | Q2 2020 | open | $89 | $144 | +62% |
| Maverick Capital | Q4 2019 | Q4 2021 | $137 | $126 | -8% |
| Bridgewater Associates | Q4 2019 | Q1 2020 | $137 | $137 | +0% |
| Viking Global Investors | Q4 2016 | Q2 2018 | $116 | $113 | -3% |
| Glenview Capital | Q4 2016 | Q3 2022 | $116 | $109 | -6% |
| JANA Partners | Q4 2016 | Q1 2018 | $116 | $113 | -3% |
| Bridgewater Associates | Q3 2016 | Q4 2016 | $121 | $114 | -5% |
| Viking Global Investors | Q2 2016 | Q3 2016 | $129 | $121 | -6% |
| Bridgewater Associates | Q4 2015 | Q1 2016 | $113 | $97 | -14% |
| Viking Global Investors | Q3 2015 | Q4 2015 | $137 | $115 | -16% |
| Viking Global Investors | Q1 2015 | Q2 2015 | $102 | $117 | +15% |
| Maverick Capital | Q1 2015 | Q3 2019 | $102 | $141 | +39% |
| Glenview Capital | Q3 2014 | Q2 2016 | $105 | $129 | +24% |
| Bridgewater Associates | Q4 2013 | Q3 2014 | $76 | $102 | +34% |
| Viking Global Investors | Q3 2013 | Q4 2014 | $68 | $93 | +36% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.